Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wightman

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Psychiatry|July 20, 2006
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled studyJames W Jefferson, A John Rush, J Craig Nelson, et al.
MMWR. Morbidity and Mortality Weekly Report|November 18, 2016
Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse - New York, 2008-2016William Eggleston, Jeanna M Marraffa, Christine M Stork, et al.
The International Journal on Drug Policy|July 9, 2023
Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode IslandAlexandra B Collins, Rachel S Wightman, E Claire Macon, et al.
Drug and Alcohol Dependence|September 5, 2021
Toxicological and pharmacologic sex differences in unintentional or undetermined opioid overdose deathRachel S Wightman, Jeanmarie Perrone, Rachel Scagos, et al.
Biological Psychiatry|November 8, 2005
Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XLJack G Modell, Norman E Rosenthal, April E Harriett, et al.
Drug and Alcohol Dependence|July 5, 2024
Trends in recurrent overdose and treatment initiation following emergency department visits for opioid overdose between 2016 and 2021Tenzin Yangchen, McClaren Rodriguez, Janette Baird, et al.
JAMA Network Open|September 18, 2023
Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of FentanylLaura C Chambers, Benjamin D Hallowell, Andrew R Zullo, et al.
Addictive Behaviors|January 11, 2026
Risk of opioid overdose during buprenorphine treatment for opioid use disorder in the fentanyl eraLaura C Chambers, Benjamin D Hallowell, Andrew R Zullo, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 5, 2021
Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist programBrendan P Jacka, Hannah N Ziobrowski, Alexis Lawrence, et al.
Journal of Psychopharmacology (Oxford, England)|January 24, 2009
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorderK Hewett, W Chrzanowski, R Jokinen, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Psychiatry|July 20, 2006
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled studyJames W Jefferson, A John Rush, J Craig Nelson, et al.
MMWR. Morbidity and Mortality Weekly Report|November 18, 2016
Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse - New York, 2008-2016William Eggleston, Jeanna M Marraffa, Christine M Stork, et al.
The International Journal on Drug Policy|July 9, 2023
Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode IslandAlexandra B Collins, Rachel S Wightman, E Claire Macon, et al.
Drug and Alcohol Dependence|September 5, 2021
Toxicological and pharmacologic sex differences in unintentional or undetermined opioid overdose deathRachel S Wightman, Jeanmarie Perrone, Rachel Scagos, et al.
Biological Psychiatry|November 8, 2005
Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XLJack G Modell, Norman E Rosenthal, April E Harriett, et al.
Drug and Alcohol Dependence|July 5, 2024
Trends in recurrent overdose and treatment initiation following emergency department visits for opioid overdose between 2016 and 2021Tenzin Yangchen, McClaren Rodriguez, Janette Baird, et al.
JAMA Network Open|September 18, 2023
Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of FentanylLaura C Chambers, Benjamin D Hallowell, Andrew R Zullo, et al.
Addictive Behaviors|January 11, 2026
Risk of opioid overdose during buprenorphine treatment for opioid use disorder in the fentanyl eraLaura C Chambers, Benjamin D Hallowell, Andrew R Zullo, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 5, 2021
Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist programBrendan P Jacka, Hannah N Ziobrowski, Alexis Lawrence, et al.
Journal of Psychopharmacology (Oxford, England)|January 24, 2009
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorderK Hewett, W Chrzanowski, R Jokinen, et al.
Pageof 7